Florida-based VITAS Healthcare is taking a more “relationship-based” approach to growth in 2025. The prospect of acquisitions is playing a larger role, with the Chemed Corp. (NYSE: CHE) subsidiary recently setting its sights on expansion across 12 states. “Our overall philosophy hasn’t changed,” Michael Witzeman, vice president, CFO and controller at Chemed Corp. said at the Bank of America Healthcare Conference conference. “On a more practical basis, the VITAS team [has] started really reaching out to Covenant-sized providers that we would be interested in talking to us about an acquisition. Historically, what we did was more so wait for people to call us. We’re being a little more proactive, particularly based on how well Covenant went for us.”
Read the full article: VITAS ‘Proactive’ in Building Hospice M&A Pipeline //
Source: https://hospicenews.com/2025/05/14/vitas-proactive-in-building-hospice-ma-pipeline